Welcome to June!

Last month’s poll let us know that most of you spend most of your time working in dysphagia. This is not surprising, since the 2021 Health Care Survey conducted by the American Speech-Language-Hearing Association (ASHA) indicated that swallowing was the most frequently treated adult diagnosis, ranked first by 33% of clinical service providers.1

 

For SLPs working in skilled nursing, 91% of their caseload has a diagnosis of dysphagia.1 And looking at the pediatric hospital setting, SLPs reported that swallowing and feeding disorder was the number one pediatric diagnosis.1

 

I can think of no better way to recognize Dysphagia Awareness Month than to read about the experiences of patients with dysphagia and their caregivers. We discussed last month the fantastic work being done by the National Foundation of Swallowing Disorders, and you can find several stories there, including a short documentary on the impact of living with dysphagia.2We as SLPs are constantly advocating for our profession to physicians, nursing… and even to our friends and family on social media! And while advocacy can sometimes get a little exhausting (for me, anyway!), reading these perspectives always reinforces to me that I am doing the right thing in providing education on what I do!

 

INDICATIONS AND USAGE | IMPORTANT SAFETY INFORMATION

VARIBAR® (barium sulfate)

IMPORTANT SAFETY INFORMATION:

For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

INDICATIONS AND USAGE | IMPORTANT SAFETY INFORMATION

VARIBAR® (barium sulfate)

Indications and Usage:

VARIBAR® THIN HONEY (barium sulfate) oral suspension, VARIBAR® NECTAR (barium sulfate) oral suspension, and VARIBAR® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR® HONEY (barium sulfate) oral suspension and VARIBAR® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:

For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please consult full Prescribing Information for VARIBAR HONEY here, for VARIBAR THIN HONEY here, for VARIBAR PUDDING here, for VARIBAR NECTAR here, and for VARIBAR THIN LIQUID here.

VARIBAR is manufactured by E-Z-EM Canada Inc., for E-Z-EM, Inc., a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 08831.

VARIBAR is a registered trademark of E-Z-EM, Inc.

See you soon,


References:1. American Speech-Language-Hearing Association. ASHA SLP Health Care 2021 Survey. https://www.asha.org/siteassets/surveys/2021-slp-hc-survey-caseload-characteristics.pdf2. National Foundation of Swallowing Disorders. Patients and Caregivers. https://swallowingdisorderfoundation.com/category/patients-and-caregivers/. Accessed April 26, 2023.

US-VARH-2300007 06/23